Prof. Dr. Andras Dinnyes presents at the 1st ICGT Congress

On 22 May, Prof. Dr. Andras Dinnyes gave a well-received talk in Paris at the 1^st Innovations for Cell and Gene Therapies (ICGT) congress organized by MabDesign and SFTCG. In his talk, he addressed the versatility of the human iPSC-based platform, with a particular emphasis on the shift from antisense oligonucleotide therapy modelling to Type-1 diabetes beta-cell therapy. The conference gathered more than 180 participants, 20 speakers, and 17 sponsors/exhibitors who could exchange ideas on the latest developments in cell & gene therapies, the emerging technologies and the new preclinical models.